DCM patients with an RBM20 (RNA-binding motif protein 20) or pathogenic DSP (desmoplakin) mutation are also considered at high risk of SCD, but no specific cut-off currently exists [23]. This evidence concerns the gene RBM20 and familial dilated cardiomyopathy.